Stocks in Play

Oncolytics Biotech Inc

09:27 AM EST - Oncolytics Biotech Inc : Announced positive clinical results from BRACELET-1, its randomized Phase 2 study evaluating pelareorep in patients with HR+/HER2- advanced or metastatic breast cancer, reinforcing path to funding of a registration-enabling study, Oncolytics Biotech Inc shares T.ONC are trading unchanged at $1.28.

Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ONC%3ACC&qmodStoryID=7632513479544973